Research on intranasal glutathione, especially in Parkinsons disease, has shown: It is generally safe and well-tolerated Imaging studies confirm higher glutathione levels in the brain after nasal administration Some trials show mild clinical benefits, though results can be mixed due to strong placebo effects and variability between subjects For users, the key takeaway is that intranasal glutathione directly targets the central nervous system in a way oral forms cannot match
BPC-157 influences growth factors involved in tissue repair
Quick Answer: CJC-1295/Ipamorelin side effects are generally mild and include injection site reactions (20-30%), mild water retention (15-25%), tingling or numbness in extremities (10-20%), increased hunger (10-15%), fatigue or drowsiness (10-15%), and headache (5-10%)
Key Takeaways Perfect B organizes longevity peptides by biological system, not by popularity
large-scale randomised controlled trials in humans are lacking
If you were doing peps prior to bloods, then you have fake peps
